May 6, 2009 – From CAF National Executive Director Gina Cioffi: As you know, clinical trials are vitally important steps in developing new therapies for thalassemia and its complications, as well as in advancing the search for a cure. Without clinical trials, there would be no chelators (oral or otherwise), no T2* measurements, no non-invasive […]